|
| ||
Wider access to brain tumour drug needed |
||
Dr Jackie Blue
National Party Associate Health
Spokeswoman
6 March 2006
Wider access to brain
tumour drug needed
National Party Associate Health spokeswoman Dr Jackie Blue is calling for wider access to the brain tumour drug Temozolomide.
Last week, Pharmac announced a provisional agreement with drug company Schering-Plough for funding Temozolomide for newly diagnosed brain tumour patients only.
"The patients who have a recurrence of their tumour miss out. This seems grossly unfair when internationally this drug is the standard of care for this group, “ says Dr Blue.
“The early trials of Temozolomide were done only in recurrent patients. If it were not for these trials, the more recent trials with newly diagnosed patients would never have eventuated.
"New Zealand's proposed access to Temozolomide for only newly diagnosed patients is at odds with Australia, Canada, the United States, the European Union, which has approved this drug for both groups, and the United Kingdom, which has approved it only for recurrent patients,” says Dr Blue.
ENDS
Review Lanuched: Electoral Commission Wants To Hear From The Public On MMP
Wellington.Scoop: After protests, Kapiti Mayor Suggests Different CEO Salary System
Werewolf: Why State Capitalism Is Beating The Free Market
Gordon Campbell: On Bank Profits, And Gerry Brownlee’s Asset Sales Plans For Christchurch
Scoop Audio: Charges Possible Over CTV Collapse
Radio NZ Audio: RadioLive To Be Referred To Police Over John Key Show
Tom Frewen:
